EP3181164B1 - Apparatus for the decapneization of blood - Google Patents

Apparatus for the decapneization of blood Download PDF

Info

Publication number
EP3181164B1
EP3181164B1 EP16204182.6A EP16204182A EP3181164B1 EP 3181164 B1 EP3181164 B1 EP 3181164B1 EP 16204182 A EP16204182 A EP 16204182A EP 3181164 B1 EP3181164 B1 EP 3181164B1
Authority
EP
European Patent Office
Prior art keywords
blood
filtering device
fact
section
main section
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16204182.6A
Other languages
German (de)
French (fr)
Other versions
EP3181164A1 (en
Inventor
Antonio Petralia
Nicola Ghelli
Paolo Fontanili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eurosets SRL
Original Assignee
Eurosets SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurosets SRL filed Critical Eurosets SRL
Publication of EP3181164A1 publication Critical patent/EP3181164A1/en
Application granted granted Critical
Publication of EP3181164B1 publication Critical patent/EP3181164B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20—Type thereof
    • A61M60/205—Non-positive displacement blood pumps
    • A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
    • A61M60/226—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly radial components
    • A61M60/232—Centrifugal pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3437—Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
    • A61M60/109—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems
    • A61M60/113—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems in other functional devices, e.g. dialysers or heart-lung machines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20—Type thereof
    • A61M60/247—Positive displacement blood pumps
    • A61M60/253—Positive displacement blood pumps including a displacement member directly acting on the blood
    • A61M60/268—Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders
    • A61M60/279—Peristaltic pumps, e.g. roller pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
    • A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
    • A61M60/37—Haemodialysis, haemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
    • A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
    • A61M60/38—Blood oxygenation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7581—General characteristics of the apparatus with filters with means for switching over to a fresh filter on clogging or saturation

Definitions

  • the present invention relates to an apparatus for the decapneization of blood.
  • decapneization is a substitutive respiratory therapy during which oxygen is supplied to the blood and, at the same time, carbon dioxide in excess is eliminated.
  • This type of therapy is generally implemented by means of the so-called “oxygenators”, which are precisely suitable for removing CO2 from the incoming blood and enriching it with oxygen.
  • Therapies are also known for the filtering of blood providing for the removal of waste substances that have accumulated in the blood for various reasons such as: pathological causes, surgical causes, administration of substances or other. These therapies are performed by means of so-called “blood-filtering machines", which implement the functions normally carried out by healthy kidneys in correct working conditions.
  • CRRT cronym for Continuous Renal Replacement Therapy
  • This kind of machines to which the patient remains connected also for long periods of time, comprise a filtering device, through which the blood to be treated is conveyed and which is connected to the patient by means of a supply line, adapted to transport the blood to be purified that is drawn from a vein of the patient, and a return line, by means of which the purified blood is reinfused into the patient.
  • the extra-renal therapy often needs to be associated with the substitutive respiratory therapy.
  • the relevant machines generally comprise a circuit that is composed of a supply line of the blood to be treated, a device for the oxygenation of blood, a filtering device, adapted to remove the waste substances present in the patient, and of a return line for the reinfusion of the treated blood into the patient.
  • EP 1 415 673 and EP 1 698 362 Some types of apparatus for the decapneization of blood are known from EP 1 415 673 and EP 1 698 362 .
  • EP 1 415 673 describes an apparatus for the decapneization in which the blood to be treated is pushed, by means of a pump, in sequence through the oxygenator and the hemofilter before being reinfused into the patient.
  • EP 1 698 362 describes, on the other hand, an apparatus for the decapneization in which the oxygenator and the hemofilter are locked together to form a single body piece.
  • the hemofilter can be by-passed, which can, however, lead to the formation of blood stasis and clots which can impair the correct operation of the oxygenator.
  • Yorgin et al. discloses a circuit for blood oxygenation with a hemofilter along a bypass line upstream from the oxygenator.
  • the main aim of the present invention is to provide an apparatus for the decapneization of blood which allows controlling the filtration of blood irrespective of the oxygenation thereof.
  • one object of the present invention is to maintain the oxygenator functioning also during the replacement or maintenance of the hemofilter.
  • one object of the present invention is to avoid, during the operation of the oxygenator and the simultaneous exclusion of the hemofilter, the formation of blood stasis.
  • Another object of the present invention is to provide an apparatus for the decapneization of blood which allows to overcome the mentioned drawbacks of the prior art within the ambit of a simple, rational, easy, effective to use and affordable solution.
  • Figure 1 is a schematic view of an apparatus according to the invention.
  • reference numeral 1 is an apparatus for the decapneization of blood.
  • the apparatus 1 comprises a supply line 2 of the blood to be treated taken from a patient, at least an oxygenation device 3 for the blood connected at input to the supply line 2, at least a filtering device 4 arranged along the supply line itself and at least a return line 5 connected at output to the oxygenation device 3 and adapted to transport the treated blood to the patient.
  • the oxygenation device 3 and the filtering device 4 are therefore both arranged along the supply line 2.
  • the supply line 2 comprises a main section, identified in the figures with reference numeral 2a, connectable on one side to the patient and connected on the opposite side to the input of the oxygenation device 3, and a by-pass section, identified in the figures with reference numeral 2b, arranged parallel to the main section 2a and along which the filtering device 4 is arranged.
  • the by-pass section 2b therefore has a delivery branch connected on one side to the main section 2a and on the opposite side to the input of the filtering device 4, and a return branch connected on one side to the output of the filtering device 4 and on the opposite side to the main section 2a.
  • the delivery branch and the return branch are identified in the figures with reference numerals 6 and 7, respectively.
  • the apparatus 1 comprises first pumping means 8 arranged along the main section 2a and adapted to convey the blood to be treated towards the oxygenation device 3.
  • the first pumping means 8 are arranged upstream of the by-pass section 2b, i.e. upstream of the delivery branch 6, with respect to the direction of advancement of the blood towards the oxygenation device 3.
  • the first pumping means 8 are of the type of a peristaltic pump or, alternatively, of a centrifugal pump. In the latter case, the centrifugal pump allows a prolonged use of the apparatus 1.
  • the apparatus 1 also comprises second pumping means 9 arranged along the by-pass section 2b and adapted to convey the blood towards the filtering device 4.
  • removable connection means 10 are arranged along the delivery branch 6 and along the return branch 7, which are adapted to allow the separation of a first portion 11 of each of the branches 6 and 7 from a relevant second portion 12, where the second portions 12 are connectable to each other by means of the connection means themselves following the separation from the relevant first portions 11.
  • a section is therefore defined that extends parallel to the main section 2a and which is devoid of blood treatment devices.
  • the second pumping means 9 are arranged along the first portion 11 of the delivery branch 6, upstream of the filtering device 4 with respect to the direction of blood flow.
  • closing means 13 are arranged, of the type of clamps or the like, operable to block the relevant blood passage channels and consequently isolate the filtering device 4.
  • the closing means 13 are therefore arranged along the delivery branch 6 and along the return branch 7, respectively upstream and downstream of the relevant connection means 10.
  • the closing means 13 are again operated to allow the passage of blood through the relevant second portions 12.
  • the apparatus 1 also comprises a discharge line 14 of the waste substances filtered by the filtering device 4, also called ultrafiltrate, which is connected on one side to the filtering device itself and on the other side to a collection bag 15.
  • a discharge line 14 of the waste substances filtered by the filtering device 4 also called ultrafiltrate
  • an infusion line 16 is also provided of at least one balancing or restoring substance connected to the by-pass section 2b.
  • the infusion line 16 is connected on one side to a bag 17 containing the balancing substance to infuse and on the opposite side to the by-pass section 2b, at the first portion 11 of the return branch 7, downstream of the filtering device 4.
  • third pumping means 18 are arranged along the infusion line 16 adapted to convey the balancing substance from the bag 17 towards the by-pass section 2b.
  • the blood taken from the patient is sent through the first pumping means 8 along the main section 2a towards the oxygenation device 3.
  • one part of the blood that runs through the main section 2a reaches the oxygenation device 3 and one part is deflected, through the second pumping means 9, along the by-pass section 2b.
  • the part of blood that runs through the delivery branch 6 of the by-pass section 2b is therefore sent by the second pumping means 9 towards the filtering device 4, later on going back inside the main section 2a through the return branch 7.
  • first portions 11 together with the filtering device 4 are removed from the connection means 10 and the second portions 12 are connected to one another.
  • the second portions 12 connected in this manner then define a section parallel to the main section 2a and devoid of blood treatment devices.
  • the passage channel defined by the second portions 12 is reopened, again through the closing means 13, the blood taken from the patient is then entirely sent to the oxygenation device 3 by means of the first pumping means 8.
  • the second portions 12 are blocked by means of the closing means 13, so as to prevent the passage of blood through the by-pass section 2b, and the second portions are separated from each other by means of the connection means 10. Subsequently the first portions 11, along which a new filtering device 4 and the second pumping means 9 are positioned, are connected again to the relevant second portions 12 by means of the connection means 10.
  • the described invention achieves the intended objects and in particular the fact is underlined that the presence of a by-pass section arranged parallel to the main section and connecting the patient to the oxygenation device allows using the filtering device as an optional treatment, without therefore constraining the filtering step to the oxygenation one.
  • the presence of the second pumping means arranged along the by-pass section allows controlling the blood flow rate which undergoes the filtering treatment according to the specific requirements.
  • a further advantage of the apparatus to which the present invention relates consists in the fact that the presence of the connection means arranged along the by-pass section allows separating the latter from the main section, in order to allow the replacement of the filtering device, at the same time maintaining the oxygenation device functioning.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Mechanical Engineering (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  • The present invention relates to an apparatus for the decapneization of blood. As known, decapneization is a substitutive respiratory therapy during which oxygen is supplied to the blood and, at the same time, carbon dioxide in excess is eliminated.
  • This type of therapy is generally implemented by means of the so-called "oxygenators", which are precisely suitable for removing CO2 from the incoming blood and enriching it with oxygen.
  • Therapies are also known for the filtering of blood providing for the removal of waste substances that have accumulated in the blood for various reasons such as: pathological causes, surgical causes, administration of substances or other. These therapies are performed by means of so-called "blood-filtering machines", which implement the functions normally carried out by healthy kidneys in correct working conditions.
  • One therapy of this type is, e.g., CRRT (acronym for Continuous Renal Replacement Therapy).
  • This kind of machines, to which the patient remains connected also for long periods of time, comprise a filtering device, through which the blood to be treated is conveyed and which is connected to the patient by means of a supply line, adapted to transport the blood to be purified that is drawn from a vein of the patient, and a return line, by means of which the purified blood is reinfused into the patient.
  • The extra-renal therapy often needs to be associated with the substitutive respiratory therapy.
  • The relevant machines generally comprise a circuit that is composed of a supply line of the blood to be treated, a device for the oxygenation of blood, a filtering device, adapted to remove the waste substances present in the patient, and of a return line for the reinfusion of the treated blood into the patient.
  • Some types of apparatus for the decapneization of blood are known from EP 1 415 673 and EP 1 698 362 .
  • EP 1 415 673 describes an apparatus for the decapneization in which the blood to be treated is pushed, by means of a pump, in sequence through the oxygenator and the hemofilter before being reinfused into the patient.
  • EP 1 698 362 describes, on the other hand, an apparatus for the decapneization in which the oxygenator and the hemofilter are locked together to form a single body piece.
  • These apparatuses of known type do have some drawbacks.
  • One drawback consists in the fact that the blood running through the supply line is constrained to pass through both the oxygenator and the hemofilter in sequence. This makes, however, impractical the simultaneous use of the two devices for a long time, because the oxygenator and the hemofilter are characterized by different operating ranges, in particular the oxygenator has a greater operating range (4/5 days approx.) than the hemofilter (24 hours approx.).
  • This drawback implies using the machine for the decapneization depending on the operating range of the hemofilter or replacing or by-passing the hemofilter while maintaining, at the same time, the oxygenator functioning.
  • In the cases in which the circuit configuration makes this possible, the hemofilter can be by-passed, which can, however, lead to the formation of blood stasis and clots which can impair the correct operation of the oxygenator. Yorgin et al. (Where should the hemofiltration circuit be placed in relation to the extracorporeal membrane oxygenation circuit?; ASAIO JOURNAL, vol. 38, no. 4; 1992-10-01) discloses a circuit for blood oxygenation with a hemofilter along a bypass line upstream from the oxygenator. The main aim of the present invention is to provide an apparatus for the decapneization of blood which allows controlling the filtration of blood irrespective of the oxygenation thereof.
  • Within this aim, one object of the present invention is to maintain the oxygenator functioning also during the replacement or maintenance of the hemofilter.
  • More particularly, one object of the present invention is to avoid, during the operation of the oxygenator and the simultaneous exclusion of the hemofilter, the formation of blood stasis.
  • Another object of the present invention is to provide an apparatus for the decapneization of blood which allows to overcome the mentioned drawbacks of the prior art within the ambit of a simple, rational, easy, effective to use and affordable solution.
  • The above mentioned objects are achieved by the present apparatus according to claim 1.
  • Other characteristics and advantages of the present invention will become better evident from the description of a preferred, but not exclusive, embodiment of an apparatus for the decapneization of blood, illustrated by way of an indicative, but non-limiting, example in the accompanying drawings, wherein:
    Figure 1 is a schematic view of an apparatus according to the invention.
  • With particular reference to such illustrations, globally indicated with reference numeral 1 is an apparatus for the decapneization of blood.
  • The apparatus 1 comprises a supply line 2 of the blood to be treated taken from a patient, at least an oxygenation device 3 for the blood connected at input to the supply line 2, at least a filtering device 4 arranged along the supply line itself and at least a return line 5 connected at output to the oxygenation device 3 and adapted to transport the treated blood to the patient.
  • The oxygenation device 3 and the filtering device 4 are therefore both arranged along the supply line 2.
  • The supply line 2 comprises a main section, identified in the figures with reference numeral 2a, connectable on one side to the patient and connected on the opposite side to the input of the oxygenation device 3, and a by-pass section, identified in the figures with reference numeral 2b, arranged parallel to the main section 2a and along which the filtering device 4 is arranged.
  • The by-pass section 2b therefore has a delivery branch connected on one side to the main section 2a and on the opposite side to the input of the filtering device 4, and a return branch connected on one side to the output of the filtering device 4 and on the opposite side to the main section 2a. The delivery branch and the return branch are identified in the figures with reference numerals 6 and 7, respectively.
  • Advantageously, the apparatus 1 comprises first pumping means 8 arranged along the main section 2a and adapted to convey the blood to be treated towards the oxygenation device 3.
  • The first pumping means 8 are arranged upstream of the by-pass section 2b, i.e. upstream of the delivery branch 6, with respect to the direction of advancement of the blood towards the oxygenation device 3.
  • The first pumping means 8 are of the type of a peristaltic pump or, alternatively, of a centrifugal pump. In the latter case, the centrifugal pump allows a prolonged use of the apparatus 1.
  • Conveniently, the apparatus 1 also comprises second pumping means 9 arranged along the by-pass section 2b and adapted to convey the blood towards the filtering device 4.
  • According to the invention, removable connection means 10 are arranged along the delivery branch 6 and along the return branch 7, which are adapted to allow the separation of a first portion 11 of each of the branches 6 and 7 from a relevant second portion 12, where the second portions 12 are connectable to each other by means of the connection means themselves following the separation from the relevant first portions 11.
  • By joining the second portions 12 together, a section is therefore defined that extends parallel to the main section 2a and which is devoid of blood treatment devices.
  • Conveniently, the second pumping means 9 are arranged along the first portion 11 of the delivery branch 6, upstream of the filtering device 4 with respect to the direction of blood flow.
  • Along the by-pass section 2b, and more particularly along the relevant second portions 12, closing means 13 are arranged, of the type of clamps or the like, operable to block the relevant blood passage channels and consequently isolate the filtering device 4. The closing means 13 are therefore arranged along the delivery branch 6 and along the return branch 7, respectively upstream and downstream of the relevant connection means 10.
  • Following the mutual linkage of the connection means 10, the closing means 13 are again operated to allow the passage of blood through the relevant second portions 12.
  • The apparatus 1 also comprises a discharge line 14 of the waste substances filtered by the filtering device 4, also called ultrafiltrate, which is connected on one side to the filtering device itself and on the other side to a collection bag 15. Preferably an infusion line 16 is also provided of at least one balancing or restoring substance connected to the by-pass section 2b.
  • More particularly, the infusion line 16 is connected on one side to a bag 17 containing the balancing substance to infuse and on the opposite side to the by-pass section 2b, at the first portion 11 of the return branch 7, downstream of the filtering device 4.
  • Conveniently, third pumping means 18 are arranged along the infusion line 16 adapted to convey the balancing substance from the bag 17 towards the by-pass section 2b.
  • The operation of the present invention is as follows.
  • In normal operating conditions, i.e. in the case in which the oxygenation device 3 and the filtering device 4 are both functioning, the blood taken from the patient is sent through the first pumping means 8 along the main section 2a towards the oxygenation device 3.
  • More in detail, one part of the blood that runs through the main section 2a reaches the oxygenation device 3 and one part is deflected, through the second pumping means 9, along the by-pass section 2b. The part of blood that runs through the delivery branch 6 of the by-pass section 2b is therefore sent by the second pumping means 9 towards the filtering device 4, later on going back inside the main section 2a through the return branch 7.
  • When it is necessary to replace the filtering device 4, in order to maintain the oxygenation device 3 functioning, the by-pass section 2b is blocked by means of the closing means 13.
  • Subsequently the first portions 11 together with the filtering device 4 are removed from the connection means 10 and the second portions 12 are connected to one another. The second portions 12 connected in this manner then define a section parallel to the main section 2a and devoid of blood treatment devices. Once the passage channel defined by the second portions 12 is reopened, again through the closing means 13, the blood taken from the patient is then entirely sent to the oxygenation device 3 by means of the first pumping means 8.
  • When the operator wishes to restore the complete functionality of the apparatus 1, by inserting again the filtering device 4, he/she should perform the aforementioned operations but in the reverse sequence. More in detail, the second portions 12 are blocked by means of the closing means 13, so as to prevent the passage of blood through the by-pass section 2b, and the second portions are separated from each other by means of the connection means 10. Subsequently the first portions 11, along which a new filtering device 4 and the second pumping means 9 are positioned, are connected again to the relevant second portions 12 by means of the connection means 10.
  • It has in practice been ascertained that the described invention achieves the intended objects and in particular the fact is underlined that the presence of a by-pass section arranged parallel to the main section and connecting the patient to the oxygenation device allows using the filtering device as an optional treatment, without therefore constraining the filtering step to the oxygenation one.
  • More in particular, the presence of the second pumping means arranged along the by-pass section allows controlling the blood flow rate which undergoes the filtering treatment according to the specific requirements.
  • A further advantage of the apparatus to which the present invention relates consists in the fact that the presence of the connection means arranged along the by-pass section allows separating the latter from the main section, in order to allow the replacement of the filtering device, at the same time maintaining the oxygenation device functioning.

Claims (10)

  1. Apparatus (1) for the decapneization of blood, comprising:
    - a supply line (2) of the blood to be treated taken from a patient and at least a return line (5) adapted to transport the treated blood to the patient;
    - at least an oxygenation device (3) and at least a filtering device (4) of the blood positioned between said supply line (2) and said return line (5);
    where said supply line (2) comprises a main section (2a), connectable on one side to the patient and connected on the opposite side to said oxygenation device (3), and a by-pass section (2b), arranged parallel to said main section (2a) and along which said filtering device (4) is arranged,
    characterized by the fact that said by-pass section (2b) comprises a delivery branch (6), connected on one side to said main section (2a) and on the other side to the input of said filtering device (4), and a return branch (7), connected on one side to the output of the filtering device (4) and on the other side to said main section (2a), and by the fact that it comprises removable connection means (10), arranged along said branches (6, 7) and adapted to allow the separation of a first portion (11) of the branches themselves which is connected to said filtering device (4), from a respective second portion (12) connected to said main section (2a), said second portions (12) being connectable to each other by means of the connection means themselves following the separation from their respective first portions (11).
  2. Apparatus (1) according to claim 1, characterized by the fact that it comprises first pumping means (8) arranged along said main section (2a), upstream of said by-pass section (2b), and adapted to convey the blood to be treated towards said oxygenation device (3).
  3. Apparatus (1) according to claim 2, characterized by the fact that said first pumping means (8) are of the type of a centrifugal pump.
  4. Apparatus (1) according to one or more of the preceding claims, characterized by the fact that it comprises second pumping means (9) arranged along said by-pass section (2b) and adapted to convey the blood to be treated towards said filtering device (4).
  5. Apparatus (1) according to one or more of the preceding claims, characterized by the fact that said second pumping means (9) are arranged downstream of said connection means (10) along the first portion (11) of said delivery branch and upstream of the filtering device (4).
  6. Apparatus (1) according to one or more of the preceding claims, characterized by the fact that it comprises closing means (13) of said by-pass section (2b) arranged along said second portions (12).
  7. Apparatus (1) according to one or more of the preceding claims, characterized by the fact that it comprises at least a discharge line (14) of the waste substances filtered by said filtering device (4), connected on one side to the filtering device itself and connectable on the other side to a collection bag (15).
  8. Apparatus (1) according to one or more of the preceding claims, characterized by the fact that it comprises at least one infusion line (16) of at least one balancing substance connected to said by-pass section (2b).
  9. Apparatus (1) according to claim 8, characterized by the fact that said infusion line (16) is connected to said by-pass section (2b) at the first portion (11) of said return branch (7), downstream of said filtering device (4).
  10. Apparatus (1) according to claim 8 or 9, characterized by the fact that it comprises third pumping means (18) arranged along said infusion line (16).
EP16204182.6A 2015-12-18 2016-12-14 Apparatus for the decapneization of blood Active EP3181164B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A009161A ITUB20159161A1 (en) 2015-12-18 2015-12-18 EQUIPMENT FOR BLOOD DECAPNIZATION

Publications (2)

Publication Number Publication Date
EP3181164A1 EP3181164A1 (en) 2017-06-21
EP3181164B1 true EP3181164B1 (en) 2018-08-15

Family

ID=55447057

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16204182.6A Active EP3181164B1 (en) 2015-12-18 2016-12-14 Apparatus for the decapneization of blood

Country Status (2)

Country Link
EP (1) EP3181164B1 (en)
IT (1) ITUB20159161A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102021109242A1 (en) 2021-04-13 2022-10-13 B.Braun Avitum Ag Extracorporeal circuit for decapneization of organic fluids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20020208A1 (en) * 2002-10-31 2004-05-01 Torre Florenziano Della EQUIPMENT USED IN HEMOFILTRATION TREATMENTS.
ITMI20030696A1 (en) * 2003-04-08 2004-10-09 Crb Nederland B V EQUIPMENT AND PROCEDURE PARTICULARLY FOR THE REPLACEMENT OF CLOSED CIRCUIT ELEMENTS FOR EXTRA-BODY CIRCULATION
ITTO20030785A1 (en) 2003-10-03 2005-04-04 Mri S R L Societa Unipersonale BLOOD FILTERING UNIT IN AN EMOFILTRATION MACHINE.
JP2007167672A (en) * 2007-02-09 2007-07-05 Senko Medical Instr Mfg Co Ltd Extracorporeal circulation circuit
JP2010528781A (en) * 2007-06-06 2010-08-26 ジョージア テック リサーチ コーポレーション A novel fluid management system for precise and continuous hemofiltration in extracorporeal membrane oxygenation therapy
CN202270211U (en) * 2011-09-28 2012-06-13 虞文魁 Integral device of extracorporeal membrane oxygenation oxygenator and hemofiltration machine
EP3237034A1 (en) * 2014-12-22 2017-11-01 Extra Corporeal Solutions S.r.l. Apparatus for the treatment of blood

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
ITUB20159161A1 (en) 2017-06-18
EP3181164A1 (en) 2017-06-21

Similar Documents

Publication Publication Date Title
US9814822B2 (en) Plasma generation with dialysis systems
US11433173B2 (en) System for extracorporeal blood treatment, treatment apparatus, kit and method for operating a system for extracorporeal blood treatment
EP0486675B1 (en) Automated blood component separation procedure and apparatus promoting different functional characteristics in multiple blood components
US8070952B2 (en) Apparatus and method for the treatment of blood
US8137299B2 (en) Wearable ultrafiltration device
KR100604460B1 (en) Hemodiafiltration/hemofiltration cartridges
US8500671B2 (en) Device for extracorporeal blood treatment in single-needle operation mode
JP4384437B2 (en) Method and apparatus for suspending extracorporeal blood treatment or continuing extracorporeal blood treatment at a modified flow rate
JP2003320023A6 (en) Method and apparatus for suspending extracorporeal blood treatment or continuing extracorporeal blood treatment at a modified flow rate
SE457056B (en) SYSTEM FOR PREPARING A SCIENTIFIC INTENDED FOR MEDICAL TREATMENT
CA2794828C (en) Connector for a fluid transport line of a medical device
JPH03170159A (en) Method and device for selective exclusion of plasma factor
EP2281591B1 (en) Wearable artificial kidney with regeneration system
EP3181164B1 (en) Apparatus for the decapneization of blood
EP3181165B1 (en) Apparatus for the decapneization of blood
EP2465555B1 (en) Method and system for providing priming and restitution liquids for an extracorporeal blood treatment
EP1698362B1 (en) Blood treatment machine and unit
EP2277572B2 (en) Dialysis machine with regeneration system
US11992588B2 (en) Blood hose set, a control device or closed-loop control device, a blood treatment apparatus and a method for the single-needle treatment
US10471200B2 (en) Blood purification apparatus
WO2005075007A1 (en) Device and apparatus for the elimination of the carbon dioxide from the blood
CN111712273A (en) Therapeutic aspects for reducing carbon dioxide levels in blood
CN109641096B (en) Blood treatment device and method for operating a blood treatment device
US20170021075A1 (en) Mid-dilution hemodiafiltration with multi-line dialysate supply
WO2013175896A1 (en) Dialysis unit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171218

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 1/36 20060101ALI20180117BHEP

Ipc: A61M 1/10 20060101ALI20180117BHEP

Ipc: A61M 1/16 20060101AFI20180117BHEP

Ipc: A61M 1/34 20060101ALI20180117BHEP

Ipc: A61M 1/32 20060101ALI20180117BHEP

INTG Intention to grant announced

Effective date: 20180208

INTG Intention to grant announced

Effective date: 20180208

INTG Intention to grant announced

Effective date: 20180220

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

Ref country code: AT

Ref legal event code: REF

Ref document number: 1029015

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016004800

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 3

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180815

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1029015

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181215

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181115

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181115

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181116

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016004800

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20190516

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181214

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181214

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181214

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20161214

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180815

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191231

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230527

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231227

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231214

Year of fee payment: 8

Ref country code: FR

Payment date: 20231227

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20231227

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231229

Year of fee payment: 8